Filing Flows › Envoy Medical (COCH) › Q3 2026
Envoy Medical (COCH) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Envoy Medical (COCH) reported revenue of $66K for the third quarter 2026 (Q3 2026), +57% from a year earlier and +29% from the quarter before.
Envoy Medical, Q3 2026: revenue $66K (+57% year over year), net loss $3.9M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $66K | +29% | +57% |
| Operating profit | −$5.5M | — | — |
| Net earnings | −$3.9M | — | — |
| Operating cash flow | −$5.0M | — | — |
What changed
Revenue was $66K in Q3 2026, up 57% year over year and up 29% from the previous quarter.
Operating costs exceeded revenue by $5.5M, an operating margin of -8389.4%. Total costs grew 6% against revenue growth of 57%. The fastest-growing cost line was Cost of revenue (+20%). The quarter ended with a net loss of $3.9M, narrower than the previous quarter's $6.0M loss. Non-operating items added $1.6M, -41% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$5.0M. Non-cash charges added back $75K of depreciation and $307K of share-based compensation. Working capital and other items used $1.5M. Capital expenditures of $27K exceeded it, leaving free cash flow of −$5.1M.
Questions
What was Envoy Medical's revenue in the third quarter 2026?
Envoy Medical (COCH) reported revenue of $66K for the third quarter 2026 (Q3 2026), +57% from a year earlier and +29% from the quarter before.
Source: Envoy Medical 10-Q on SEC EDGAR.